TD Cowen Reiterates Hold Rating on Tempus AI Inc (TEM) Dec 8, 2025 05:30AM
Tempus AI valuation catches up with its growth, says TD Cowen downgrading stock Oct 21, 2025 09:21AM
TD Cowen Downgrades Tempus AI Inc (TEM) to Hold Oct 21, 2025 05:26AM
Tempus AI Inc (TEM) PT Raised to $72 at TD Cowen Aug 13, 2025 10:27AM
Tempus to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference Jun 17, 2025 08:30AM


Jun 2, 2025 08:47AM TD Cowen Defends Tempus AI Inc (TEM): 'Stock Reaction Looks Overdone'
Feb 19, 2025 08:30AM Tempus to Present at TD Cowen's 45th Annual Health Care Conference
Feb 5, 2025 07:00AM TD Cowen Reinstates Tempus AI Inc (TEM) at Buy
Nov 4, 2024 04:01PM Tempus AI (TEM) to Acquire Ambry Genetics, Reports Q3
Nov 4, 2024 04:01PM Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics
Jul 9, 2024 10:16AM Wall Street analysts bullish on genetic testing firm Tempus AI
Jul 9, 2024 05:54AM TD Cowen Starts Tempus AI Inc (TEM) at Buy, 'largest oncology Dx co.'
Jun 17, 2024 05:42AM Tempus AI (TEM) Prices 11.1M Share IPO at $37/sh
Jun 14, 2024 11:50AM Tempus AI (TEM) IPO Opens Higher by 8%
Jun 13, 2024 06:44PM Tempus Announces Pricing of Initial Public Offering